FDA Faces Avandia Decision: "A panel of outside medical experts is scheduled to meet on Tuesday to discuss the possibility of the U.S. Food and Drug Administration (FDA) pulling the type 2 diabetes drug rosiglitazone (Avandia) from the U.S. market."
Welcome
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment